Gemcitabine-Associated Atypical Hemolytic-Uremic Syndrome Treated with Eculizumab

被引：0
|
作者：
Plesa, A. [1 ]
Suarez, A. [1 ]
机构：
[1] London Hlth Sci Ctr, London, ON, Canada
来源：
CANADIAN JOURNAL OF HOSPITAL PHARMACY | 2020年 / 73卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：77 / 78
页数：2
相关论文
共 50 条
  • [1] Gemcitabine-associated hemolytic-uremic syndrome
    Walter, RB
    Joerger, M
    Pestalozzi, BC
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (04)
  • [2] Eculizumab in Atypical Hemolytic-Uremic Syndrome
    Ring, Troels
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1377 - 1378
  • [3] Eculizumab in Atypical Hemolytic-Uremic Syndrome Reply
    Legendre, Christophe M.
    Licht, Christoph
    Loirat, Chantal
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1379 - 1380
  • [4] Eculizumab for Atypical Hemolytic-Uremic Syndrome.
    Nuernberger, Jens
    Witzke, Oliver
    Saez, Anabelle Opazo
    Vester, Udo
    Baba, Hideo Andreas
    Kribben, Andreas
    Zimmerhackl, Lothar Bernd
    Janecke, Andreas R.
    Nagel, Mato
    Kirschfink, Michael
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05): : 542 - 544
  • [5] Eculizumab for Congenital Atypical Hemolytic-Uremic Syndrome.
    Gruppo, Ralph A.
    Rother, Russell P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05): : 544 - 546
  • [6] More on Eculizumab for Congenital Atypical Hemolytic-Uremic Syndrome
    Shin, Jae Il
    Lee, Jae Seung
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (20): : 2142 - 2143
  • [7] Atypical hemolytic-uremic syndrome due to scleroderma renal crisis treated with eculizumab
    Skonieczny, Piotr
    Wojteczek, Anna
    Zdrojewski, Zbigniew
    Debska-Slizien, Alicja
    [J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2023, 133 (02):
  • [8] ATYPICAL HEMOLYTIC UREMIC SYNDROME TREATED WITH ECULIZUMAB
    Khawar, M. U.
    Bhutta, U.
    Haragsim, L.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (02) : 410 - 410
  • [9] More on Eculizumab for Congenital Atypical Hemolytic-Uremic Syndrome Reply
    Gruppo, Ralph A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (20): : 2143 - 2143
  • [10] Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
    Legendre, C. M.
    Licht, C.
    Muus, P.
    Greenbaum, L. A.
    Babu, S.
    Bedrosian, C.
    Bingham, C.
    Cohen, D. J.
    Delmas, Y.
    Douglas, K.
    Eitner, F.
    Feldkamp, T.
    Fouque, D.
    Furman, R. R.
    Gaber, O.
    Herthelius, M.
    Hourmant, M.
    Karpman, D.
    Lebranchu, Y.
    Mariat, C.
    Menne, J.
    Moulin, B.
    Nuernberger, J.
    Ogawa, M.
    Remuzzi, G.
    Richard, T.
    Sberro-Soussan, R.
    Severino, B.
    Sheerin, N. S.
    Trivelli, A.
    Zimmerhackl, L. B.
    Goodship, T.
    Loirat, C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (23): : 2169 - 2181
12345